Nakai Mikizo, Okuyama Michihiro, Shimizu Shuji, Kato Gentaro, Ochi Yoshiki, Okada Masahiro
Department of Cardiovascular Surgery, Okayama Medical Center, Okayama, Japan.
Kyobu Geka. 2011 Jan;64(1):69-73.
In contrast to high mortality of open surgery for thoracic aortic catastrophes including ruptured thoracic aortic aneurysm (RTAA) and traumatic aortic injury (TAI), excellent short-term outcomes of thoracic endovascular aortic repair (TEVAR) have recently been reported. We report our single-center experiences with TEVAR for aortic catastrophes. Thirteen patients with thoracic aortic catastrophes (RTAA in 7 patients, TAI in 6 patients) have received TEVAR from February 2004 to June 2010. In cases of RTAA, 5 descending aortic aneurysm ruptures and 2 aortic arch aneurysm ruptures were included. In patients with arch aneurysm ruptures, fenestrated stent grafting (SG) and SG combined with arch debranching were performed. In all cases of TAI, aortic injuries occurred near the isthmus and 5 patients received fenestrated SG. The initial success rate was 100% and there was no perioperative death. Mean duration of observation was 24 months, which revealed 4 late deaths. The causes of late death were liver failure, cerebral contusion, senility and unknown. A patient with RTAA experienced a type III endoleak as an aorta-related event 24 months after operation. There was no enlargement of aneurysm in any patient. TEVAR for aortic catastrophes seems to be performed safely with acceptable outcomes. Although morphological incompatibility, unstable preoperative haemodynamics and longer time for preparation may become impediments to perform TEVAR, we believe that TEVAR should be the 1st choice for life-threatening aortic catastrophes. However, a careful follow-up is necessary because TEVAR has several unique late complications.
与包括胸主动脉瘤破裂(RTAA)和创伤性主动脉损伤(TAI)在内的胸主动脉灾难性疾病的开放手术高死亡率形成对比的是,最近有报道称胸主动脉腔内修复术(TEVAR)具有出色的短期疗效。我们报告我们单中心应用TEVAR治疗主动脉灾难性疾病的经验。2004年2月至2010年6月,13例胸主动脉灾难性疾病患者(7例RTAA,6例TAI)接受了TEVAR治疗。在RTAA病例中,包括5例降主动脉瘤破裂和2例主动脉弓瘤破裂。对于主动脉弓瘤破裂患者,实施了开窗支架植入术(SG)以及SG联合主动脉弓去分支术。在所有TAI病例中,主动脉损伤均发生在峡部附近,5例患者接受了开窗SG。初始成功率为100%,且无围手术期死亡。平均观察期为24个月,有4例晚期死亡。晚期死亡原因分别为肝功能衰竭、脑挫伤、衰老及原因不明。1例RTAA患者术后24个月发生Ⅲ型内漏这一与主动脉相关的事件。所有患者的动脉瘤均未增大。TEVAR治疗主动脉灾难性疾病似乎可安全实施且疗效可接受。尽管形态不匹配、术前血流动力学不稳定以及准备时间较长可能会成为实施TEVAR的障碍,但我们认为TEVAR应成为危及生命的主动脉灾难性疾病的首选治疗方法。然而,由于TEVAR存在一些独特的晚期并发症,因此有必要进行仔细的随访。